AR120350A1 - Métodos de uso de composiciones de cannabinoides en aplicaciones de medicina deportiva - Google Patents

Métodos de uso de composiciones de cannabinoides en aplicaciones de medicina deportiva

Info

Publication number
AR120350A1
AR120350A1 ARP200103006A ARP200103006A AR120350A1 AR 120350 A1 AR120350 A1 AR 120350A1 AR P200103006 A ARP200103006 A AR P200103006A AR P200103006 A ARP200103006 A AR P200103006A AR 120350 A1 AR120350 A1 AR 120350A1
Authority
AR
Argentina
Prior art keywords
injury
methods
compositions
oil
composition
Prior art date
Application number
ARP200103006A
Other languages
English (en)
Inventor
Peyton Palaio
Original Assignee
Prec Biologics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prec Biologics filed Critical Prec Biologics
Publication of AR120350A1 publication Critical patent/AR120350A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se proporcionan composiciones que comprenden un cannabinoide, un aceite (por ejemplo, aceite MCT o aceite de coco) y una cera, y métodos para preparar tales composiciones. Las composiciones divulgadas pueden ser útiles, por ejemplo, en el tratamiento de una lesión del músculo, articulación, cartílago y/o tendón. Este resumen está destinado a ser una herramienta de exploración con el propósito de buscar en la técnica particular y no pretende ser una limitación de la presente. Reivindicación 1: Una composición que comprende: (a) un cannabinoide en una cantidad de aproximadamente 10% en peso a aproximadamente 14% en peso; (b) un aceite; y (c) una cera. Reivindicación 17: Un kit que comprende la composición de la reivindicación 1, y uno o más de: (a) un agente conocido para el tratamiento del dolor; y (b) instrucciones para tratar una lesión seleccionada de una lesión muscular, una lesión articular, una lesión del cartílago, una lesión del tendón o una combinación de las mismas, en donde la composición y el agente no están coformulados.
ARP200103006A 2019-10-30 2020-10-30 Métodos de uso de composiciones de cannabinoides en aplicaciones de medicina deportiva AR120350A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962928206P 2019-10-30 2019-10-30

Publications (1)

Publication Number Publication Date
AR120350A1 true AR120350A1 (es) 2022-02-09

Family

ID=75686693

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP200103006A AR120350A1 (es) 2019-10-30 2020-10-30 Métodos de uso de composiciones de cannabinoides en aplicaciones de medicina deportiva

Country Status (4)

Country Link
US (1) US20210128521A1 (es)
AR (1) AR120350A1 (es)
UY (1) UY38939A (es)
WO (1) WO2021086964A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11058142B1 (en) 2020-10-01 2021-07-13 Tobacco Technology, Inc. Shisha, heat-not-burn, or combustion casing with active ingredient, product and casing with active ingredient, and method of making the same
US11363834B2 (en) 2020-10-01 2022-06-21 Tobacco Technology, Inc. Shisha, heat-not-burn, or combustion casing, product, and method of making the same
CA3235080A1 (en) 2021-10-26 2023-04-05 Alexandra M CAPANO Methods of treating endometriosis and other non-cancer gynecological disorders with hemp extract
CA3235074A1 (en) 2021-10-26 2023-05-04 Alexandra M CAPANO Methods of treating ovarian cancer with hemp extract
EP4422769A2 (en) 2021-10-26 2024-09-04 Ecofibre USA Inc. Systems and methods for producing hemp extracts and compositions
US12011451B2 (en) 2022-10-26 2024-06-18 Ecofibre USA Inc. Stabilized compositions comprising cannabidiol
US12097211B2 (en) 2022-10-26 2024-09-24 Ecofibre USA Inc. Methods of treating estrogen sensitive diseases with cannabis extract

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6949582B1 (en) * 1999-05-27 2005-09-27 Wallace Walter H Method of relieving analgesia and reducing inflamation using a cannabinoid delivery topical liniment
US10052339B2 (en) * 2014-03-21 2018-08-21 Bodybio Inc. Methods and compositions for treating symptoms of diseases related to imbalance of essential fatty acids
US20160338974A1 (en) * 2015-03-02 2016-11-24 Afgin Pharma, Llc Topical regional neuro affective therapy with cannabinoid combination products
ES2977485T3 (es) * 2018-03-14 2024-08-26 Poviva Corp Administración transdérmica y/o dérmica de agentes activos lipofílicos
WO2019186544A1 (en) * 2018-03-26 2019-10-03 Raphael Luxenbourg Topical cannabidiol compositions and methods for protecting the skin from ultra-violet radiation

Also Published As

Publication number Publication date
UY38939A (es) 2022-04-29
WO2021086964A1 (en) 2021-05-06
US20210128521A1 (en) 2021-05-06

Similar Documents

Publication Publication Date Title
AR120350A1 (es) Métodos de uso de composiciones de cannabinoides en aplicaciones de medicina deportiva
CL2022003434A1 (es) Compuestos para tratar la enfermedad de huntington (divisional solicitud 202003378)
BR0113042A (pt) Composto da fórmula ou um seu solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica, método para o tratamento de um indivìduo humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para preparar um composto ou um seu solvato
BRPI0501092A (pt) Composições de elastÈmero de fluorocarbono curadas com peróxido
MX167917B (es) Nuevos materiales y dispositivos quirurgicos
PE20011210A1 (es) Composiciones de almidon procesables por fusion
BR0204012A (pt) Composição cosmética contendo um copolìmero de ácido metacrìlico e um óleo, processo de tratamento das matérias queratìnicas, uso de um copolìmero reticulado e uso de uma composição
MX9300372A (es) Mezclas que contienen glicoles para acelerar el fraguado del cemento hidraulico, composiciones de cemento que las contienen y metodo para la preparacion de dichas composiciones.
Behmanesh et al. Effects of olive oil sitz bath on improvement of perineal injury after delivery
ES2087160T3 (es) Composiciones y procedimiento para el tratamiento de trastornos dolorosos, inflamatorios o alergicos.
Eiken et al. Anomalous distal branching of the median nerve
BR0016089A (pt) Composição refrigerante, uso de uma composição, processo para produzir refrigeração, e, aparelho de refrigeração
Anderson et al. Opponensplasty by extensor indicis and flexor digitorum superficialis tendon transfer
BR9715034A (pt) Composição agroquìmica, processo de tratamento agroquìmico, sementes de arroz e massa ou conjunto de sementes de arroz
Anderson et al. Fractures of the odontoid process of the axis
Boyes Repair of the motor branch of the ulnar nerve in the palm
Semb The breaking strength of normal and immobilized cortical bone from dogs
Cowell et al. Bilateral tendonitis of the flexor hallucis longus in a ballet dancer
Brodetti An experimental study on the use of nails and bolt screws in the fixation of fractures of the femoral neck
BR112022004328A2 (pt) Processo para reduzir a evolução em poeira de grânulos à base de sais inorgânicos ou ureia, uso de uma combinação, composição de óleo e grânulos
ES2112832T3 (es) Derivados carbamoilicos.
CL2022000345A1 (es) Solvatos de ácido abscísico y composiciones líquidas que contienen ácido abscísico
CL2019000118A1 (es) Composiciones de l-triptófano y uso de las mismas.
Haxton The patellar index in mammals
Popovic RESEARCH AND WRITING DEVELOPMENT IN THE AREA OF SPORT SCIENCE PUBLISHING IN MONTENEGRO FROM 2002 TO 2017.